Hypermobility and Ehlers-Danlos Syndrome in Autism

Overview of Hypermobility and Ehlers-Danlos Syndrome

Joint hypermobility refers to joints that move beyond the typical range, often due to lax connective tissue. When this leads to chronic pain, instability, or other systemic symptoms, it may be diagnosed as hypermobility spectrum disorder (HSD) or hypermobile Ehlers-Danlos syndrome (hEDS), a genetic connective tissue disorder [1][2]. hEDS is characterized by stretchy skin, fragile tissues, and often dysautonomia (autonomic nervous system dysfunction) [1][6].

The Link to Autism

Research indicates a higher prevalence of hypermobility and hEDS among autistic individuals compared to the general population. Studies suggest up to 80% of autistic people may experience joint hypermobility, though estimates vary [12][13]. The connection may stem from shared genetic and neurological factors, such as collagen abnormalities affecting both connective tissue and brain development [4][7]. Some researchers propose that hEDS/HSD could represent a subtype of autism, with overlapping sensory and motor challenges [10][11].

Possible Shared Mechanisms

• Collagen Dysregulation: Collagen, a structural protein, is impaired in hEDS and may also affect neural connectivity in autism [4][7].
• Dysautonomia: Autonomic dysfunction (e.g., POTS) is common in both conditions, potentially exacerbating fatigue and sensory issues [1][8].
• Proprioceptive Differences: Hypermobility can disrupt body awareness, compounding motor coordination challenges in autism [6][12].

Signs and Presentation

Autistic individuals with hypermobility or hEDS may experience:

• Chronic pain (joint instability, frequent subluxations) [0][9].
• Fatigue (due to dysautonomia or compensatory muscle use) [1][8].
• Motor difficulties (clumsiness, poor handwriting) [1][12].
• Sensory sensitivities (linked to connective tissue nerve endings) [4][8].

These symptoms are often misattributed solely to autism, delaying hEDS/HSD diagnosis [1][9].

Prevalence and Diagnosis

While exact co-occurrence rates are unclear, studies suggest 20-30% of hEDS/HSD patients may be autistic, and hypermobility is significantly more common in autistic populations [10][12]. Diagnosis involves:

• Clinical evaluation (Beighton score for hypermobility).
• Rule-outs for other connective tissue disorders [2][6].

Challenges include overlapping symptoms (e.g., executive dysfunction from fatigue vs. autism) and lack of provider awareness [1][8].

Management Strategies

Treatment focuses on symptom relief and prevention: 1. Physical Therapy: Strengthening muscles to stabilize joints (avoiding overstretching) [6][12]. 2. Pain Management: Heat therapy, gentle exercise, and medications (e.g., NSAIDs) [0][9]. 3. Dysautonomia Support: Hydration, compression garments, and pacing activities [1][8]. 4. Sensory Adaptations: Supportive seating, orthotics, and proprioceptive input (e.g., weighted blankets) [12][13].

Current Research Gaps

While the association is clear, causal mechanisms remain uncertain. The "connectivome theory" proposes a framework linking connective tissue and neural atypicalities in autism [7], but more studies are needed. Limitations include small sample sizes and reliance on retrospective data [4][10].

Key Takeaways

• Hypermobility/hEDS is overrepresented in autism, likely due to shared biological pathways.
• Co-occurrence can worsen pain, fatigue, and motor challenges, requiring integrated care.
• Diagnosis and management should be multidisciplinary (rheumatology, neurology, OT) [2][8].

Note: This is an evolving field; recommendations may shift with new evidence.